Optimal dose selection
PROTEINA can provide guidelines for the optimal dose of a drug in development
The US FDA has announced the Project Optimus initiative which will mandate the establishment of
an optimal dose of a pharmaceutical compound rather than the traditional maximum tolerated dose.
Pharmaceutical developers can leverage PROTEINA's platform to create the data they need to determine
the optimal dose of drug to administer to patients in order to maintain FDA compliance.